These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6310788)
1. [Comparative pharmacokinetics of moxalactam and other cephalosporins]. Fourtillan JB; Brisson AM Sem Hop; 1983 Jun; 59(26):1968-71. PubMed ID: 6310788 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of moxalactam in adults]. Humbert G; Leroy A; Fillastre JP Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787 [TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers. Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of moxalactam in patients with normal and impaired renal function. Aronoff GR; Sloan RS; Luft FC J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824 [TBL] [Abstract][Full Text] [Related]
9. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion. Polk R; Hume A; Kline BJ; Cardea J Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858 [TBL] [Abstract][Full Text] [Related]
10. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion. Polk RE; Kline BJ; Markowitz SM Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759 [TBL] [Abstract][Full Text] [Related]
11. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387 [TBL] [Abstract][Full Text] [Related]
12. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Srinivasan S; Fu KP; Neu HC Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects. Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235 [TBL] [Abstract][Full Text] [Related]